PVX-410
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for PVX-410, covering 2022-04-20 to 2026-03-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study of PVX-410, a Cancer Vaccine, and Citarinostat +/- Lenalidomide for Smoldering MM [Phase 1]